Literature DB >> 9145978

The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: a multivariate analysis of positive surgical margins.

I J Powell1, L K Heilbrun, W Sakr, D Grignon, J Montie, M Novallo, D Smith, J E Pontes.   

Abstract

OBJECTIVES: Several investigators have reported that African-American men with clinically localized prostate cancer have poorer survival than do white men. In addition, prostate cancer in African-American men is commonly diagnosed at a more advanced stage of disease. Is race or ethnicity predictive of outcome of clinically localized prostate cancer? It has been reported that the presence of positive surgical margins significantly influences time to progression independently of other prognostic factors. Therefore, we have elected to conduct a multivariate analysis of clinical factors including race as potential predictors of positive surgical margin outcome.
METHODS: We studied 369 consecutive men (120 African-American and 249 white) who had radical prostatectomies at a single institution. Comparisons by race of Gleason score, stage, presence of positive surgical margins, and mean preoperative prostate-specific antigen (PSA) level were carried out.
RESULTS: Our data demonstrate that African-American men have more pathologically locally advanced prostate cancer than do white American men: 69% among blacks compared with 57% among whites. However, the difference in rate of positive surgical margins between blacks and whites is statistically significant: 58% among blacks versus 40% among whites (P = 0.002). Four factors were predictive of positive surgical margins: preoperative PSA level, race, clinical stage, and Gleason score.
CONCLUSIONS: We have demonstrated that race is an independent predictor of positive surgical margins among patients with clinically localized prostate cancer and should be included in treatment decisions. In addition, the risk of positive surgical margins increases noticeably when PSA is greater than 10 ng/mL.

Entities:  

Mesh:

Year:  1997        PMID: 9145978     DOI: 10.1016/S0090-4295(96)00618-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

Review 1.  Racial differences in the androgen/androgen receptor pathway in prostate cancer.

Authors:  C A Pettaway
Journal:  J Natl Med Assoc       Date:  1999-12       Impact factor: 1.798

2.  Ethnic variation in pelvimetric measures and its impact on positive surgical margins at radical prostatectomy.

Authors:  Christian von Bodman; Mika P Matikainen; Luis Herran Yunis; Vincent Laudone; Peter T Scardino; Oguz Akin; Farhang Rabbani
Journal:  Urology       Date:  2010-11       Impact factor: 2.649

3.  Relationship of early-onset baldness to prostate cancer in African-American men.

Authors:  Charnita Zeigler-Johnson; Knashawn H Morales; Elaine Spangler; Bao-Li Chang; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-26       Impact factor: 4.254

Review 4.  Minireview: the molecular and genomic basis for prostate cancer health disparities.

Authors:  Isaac J Powell; Aliccia Bollig-Fischer
Journal:  Mol Endocrinol       Date:  2013-04-22

5.  Investigation of Mitochondrial Metabolic Response to Doxorubicin in Prostate Cancer Cells: An NADH, FAD and Tryptophan FLIM Assay.

Authors:  Shagufta Rehman Alam; Horst Wallrabe; Zdenek Svindrych; Ajay K Chaudhary; Kathryn G Christopher; Dhyan Chandra; Ammasi Periasamy
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

6.  Pathological upgrading and upstaging at radical prostatectomy in Jamaican men with low-risk prostate cancer.

Authors:  Belinda F Morrison; William D Aiken; Gareth Reid; Richard Mayhew; Barrie Hanchard
Journal:  Ecancermedicalscience       Date:  2019-10-29

Review 7.  The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine.

Authors:  Deyana D Lewis; Cheryl D Cropp
Journal:  Genes (Basel)       Date:  2020-12-08       Impact factor: 4.096

8.  Mitochondrial dysfunction-mediated apoptosis resistance associates with defective heat shock protein response in African-American men with prostate cancer.

Authors:  Ajay K Chaudhary; Tariq A Bhat; Sandeep Kumar; Anil Kumar; Rahul Kumar; Willie Underwood; Shahriar Koochekpour; Mojgan Shourideh; Neelu Yadav; Shanta Dhar; Dhyan Chandra
Journal:  Br J Cancer       Date:  2016-04-26       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.